Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors and the Risk of Cardiovascular Events Among Patients With Type 2 Diabetes: a Multicenter Cohort Study

NCT03939624 is registered in ClinicalTrials.gov with Canadian Network for Observational Drug Effect Studies, CNODES as lead sponsor.

NCT NCT03939624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03939624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors and the Risk of Cardiovascular Events Among Patients With Type 2 Diabetes: a Multicenter Cohort Study
Lead sponsor
Canadian Network for Observational Drug Effect Studies, CNODES
Phase
Observational
Overall status
Completed
Start date
October 1, 2018
Completion date
October 1, 2019
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

all-cause mortality, cardiovascular death, heart failure, ischemic stroke, myocardial infarction, type2 diabetes